4//SEC Filing
KARBE FRANK 4
Accession 0001209191-22-032578
CIK 0001783183other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:41 PM ET
Size
5.5 KB
Accession
0001209191-22-032578
Insider Transaction Report
Form 4
KARBE FRANK
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+10,000→ 10,000 totalExercise: $7.40Exp: 2032-05-24→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to one-third of the shares of common stock on April 25, 2023, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001276700
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:41 PM ET
- Size
- 5.5 KB